What This Report
Will Provide?
This study involved four major
activities in estimating the current size of the lab automation market.
Exhaustive secondary research was carried out to collect information on the
market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with
industry experts across the value chain through primary research. Both top-down
and bottom-up approaches were employed to estimate the complete market size.
After that, market breakdown and data triangulation procedures were used to
estimate the size of segments and subsegments.
Expected Revenue Growth:
The global lab automation market size is projected to grow from an estimated
USD 4.3 billion in 2020 to USD 5.5 billion by 2025, at a CAGR of 5.2%
Major Growth Boosters:
Market growth is driven
largely by factors, such as increasing expenditure on research &
development by pharmaceutical companies, and Strict regulation for healthcare.
The improving healthcare infrastructure across emerging countries, and growth
of the pharmaceutical and biotechnology industries are expected to present
avenues of growth for market players.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1158
Recent Developments:
In February 2020, Thermo Fisher Scientific, Inc. Launched Rapid EZ DNA-Seq library preparation
kit, offering PCR-free generation of sequencing-ready libraries for NGS
In July 2020, Danaher Corporation(Beckman Coulter, Inc.) entered into a
marketing agreement with Clever Culture Systems (CCS), a leader in microbiology
automation using AI, to promote the APAS Independence in their suite of lab
automation solutions
In July 2019, Agilent Technologies, Inc. acquired BioTek Instruments (US to
enhance Agilent’s portfolio with BioTek’s life science instrumentation and
provide integrated solutions to customers in the fast-growing area of live-cell
analysis
Key Market Driver: Increased R&D Investment in Pharmaceuticals Industries:
Pharmaceutical
and biotechnology companies are making significant investments in research to
meet the growing needs of the healthcare sector. For instance, According to the
India Brand Equity Foundation (IBEF), pharmaceutical companies such as Sun
Pharmaceuticals, Cipla, and Lupin Ltd. invested 8.8% of their sales in R&D
in FY 2018.Moreover,collaborations between pharma companies and healthcare
stakeholders for R&D into therapeutics will also stimulate the use of lab
automation., hence exceeding the production levels this will likely to drive
the demand of Lab Automation market.
Key Questions Addressed in The Report:
1. Who are the top 10 players
operating in the global lab automation market?
2. What are the drivers, restraints, opportunities, and challenges in the lab
automation Industry?
3. What are the opportunities for stakeholders and provide details of the
competitive landscape for key players?
4. What will be growth of lab automation in North America, Europe, Asia
Pacific, Latin America, and the Middle East and Africa?
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1158
Regional Growth Analysis:
North
America, Europe, Asia Pacific, Latin America, and Middle East & Africa are
the major regions considered for the study of the Lab Automation market. North
America is expected to dominate the market during the forecast period. Owing to
the presence of large pharmaceutical companies, increasing investment in drug
discovery and genomics market. This is expected to drive market growth for lab
automation industry.
Leading Players:
The major players in the global Lab
Automation market Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc, (US)
Agilent Technologies (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd.
(Switzerland), and Tecan Group Ltd. (Switzerland).